title: Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations.
abstract: Most clinical blood biomarkers lack the necessary sensitivity and specificity to reliably detect cancer at an early stage, when it is best treatable. It is not yet clear how early a clinical blood assay can be used to detect cancer or how biomarker-based strategies can be improved to enable earlier detection of smaller tumors. To address these issues, we developed a mathematical model describing dynamic plasma biomarker kinetics in relation to the growth of a tumor, beginning with a single cancer cell. To exemplify a realistic scenario in which biomarker is shed by both cancerous and noncancerous cells, we primed the model on ovarian tumor growth and CA125 shedding data, for which tumor growth parameters and shedding rates are readily available in published literature. We found that a tumor could grow unnoticed for more than 10.1 years and reach a volume of about π/6(25.36 mm)(3), corresponding to a spherical diameter of about 25.36 mm, before becoming detectable by current clinical blood assays. Model parameters were perturbed over log orders of magnitude to quantify ideal shedding rates and identify other blood-based strategies required for early submillimeter tumor detectability. The detection times we estimated are consistent with recently published tumor progression time lines based on clinical genomic sequencing data for several cancers. Here, we rigorously showed that shedding rates of current clinical blood biomarkers are likely 10(4)-fold too low to enable detection of a developing tumor within the first decade of tumor growth. The model presented here can be extended to virtually any solid cancer and associated biomarkers.
authors.affiliation: Department of Radiology, Molecular Imaging Program at Stanford, Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305-5427, USA.
authors.forename: Sharon S
authors.initials: SS
authors.lastname: Hori
authors.forename: Sanjiv S
authors.initials: SS
authors.lastname: Gambhir
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D055088:Early Detection of Cancer / Q000379:methods*; D005260:Female; D006801:Humans; D008962:Models, Theoretical; D009369:Neoplasms / Q000097:blood* / Q000175:diagnosis*; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis
chemical_list: D014408:Biomarkers, Tumor
references.citation: Gut. 2010 Jun;59(6):706-8
references.pmid: 20551450
references.citation: Obstet Gynecol. 1987 Feb;69(2):223-7
references.pmid: 2433652
references.citation: Biomark Med. 2010 Jun;4(3):437-9
references.pmid: 20550476
references.citation: PLoS Med. 2008 Aug 19;5(8):e170
references.pmid: 18715113
references.citation: Nature. 2008 Apr 3;452(7187):571-9
references.pmid: 18385731
references.citation: Am J Obstet Gynecol. 2008 Sep;199(3):215-23
references.pmid: 18468571
references.citation: Nature. 2010 Oct 28;467(7319):1053-5
references.pmid: 20981088
references.citation: Obstet Gynecol. 1986 Apr;67(4):473-7
references.pmid: 3008052
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4283-8
references.pmid: 18337506
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
references.pmid: 18663219
references.citation: Nature. 2010 Oct 28;467(7319):1114-7
references.pmid: 20981102
references.citation: Nature. 2011 Jan 13;469(7329):156-7
references.pmid: 21228852
references.citation: Am J Clin Pathol. 2006 Jun;125(6):921-7
references.pmid: 16690492
references.citation: Biochim Biophys Acta. 2009 Dec;1796(2):176-93
references.pmid: 19406210
references.citation: PLoS Med. 2009 Jul;6(7):e1000114
references.pmid: 19636370
references.citation: Nat Rev Cancer. 2010 Dec;10(12):871-7
references.pmid: 21048784
references.citation: Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17152-7
references.pmid: 19805109
references.citation: Nat Med. 2009 Nov;15(11):1327-32
references.pmid: 19820717
references.citation: Nat Clin Pract Oncol. 2008 Oct;5(10):588-99
references.pmid: 18695711
references.citation: Eur J Obstet Gynecol Reprod Biol. 2011 Mar;155(1):99-105
references.pmid: 21211896
references.citation: Nature. 2009 Oct 15;461(7266):890-1
references.pmid: 19829362
references.citation: JAMA. 1993 Mar 3;269(9):1123-6
references.pmid: 8433467
references.citation: Cancer Res. 1984 Mar;44(3):1048-53
references.pmid: 6198078
references.citation: Br J Cancer. 1989 Oct;60(4):634-7
references.pmid: 2803938
references.citation: Br J Cancer. 1965 Jun;19:278-91
references.pmid: 14316202
references.citation: Nat Rev Cancer. 2002 Apr;2(4):266-76
references.pmid: 12001988
references.citation: Science. 2005 Jan 7;307(5706):58-62
references.pmid: 15637262
references.citation: N Engl J Med. 1983 Oct 13;309(15):883-7
references.pmid: 6310399
references.citation: Cancer Lett. 2010 Aug 28;294(2):139-46
references.pmid: 20363069
references.citation: Biomark Med. 2008 Jun;2(3):291-303
references.pmid: 20477415
references.citation: Clin Chem. 1986 Nov;32(11):2110-1
references.pmid: 3465487
references.citation: Biotechnol Lett. 2007 Jul;29(7):1019-24
references.pmid: 17401545
references.citation: Cancer Res. 1965 Jun;25:727-31
references.pmid: 14347560
references.citation: Nature. 1976 Dec 9;264(5586):542-5
references.pmid: 1004590
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3687-92
references.pmid: 16505370
references.citation: Nature. 2005 Jun 9;435(7043):834-8
references.pmid: 15944708
references.citation: Nat Rev Cancer. 2006 Dec;6(12):961-7
references.pmid: 17093504
references.citation: Methods. 2010 Apr;50(4):298-301
references.pmid: 20146939
references.citation: Anal Bioanal Chem. 2009 Mar;393(5):1521-3
references.pmid: 19145430
references.citation: Gynecol Oncol. 1996 Sep;62(3):384-9
references.pmid: 8812537
references.citation: Nat Rev Cancer. 2003 Apr;3(4):243-52
references.pmid: 12671663
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16284-9
references.pmid: 18936480
references.citation: Clin Chem. 1993 Dec;39(12):2509-13
references.pmid: 8252723